###begin article-title 0
Deletion of Cd39/Entpd1 Results in Hepatic Insulin Resistance
###end article-title 0
###begin p 1
###xml 39 64 39 64 <email xmlns:xlink="http://www.w3.org/1999/xlink">kenjoji@bidmc.harvard.edu</email>
Corresponding author: Keiichi Enjyoji, kenjoji@bidmc.harvard.edu
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-Extracellular nucleotides are important mediators of inflammatory responses and could also impact metabolic homeostasis. Type 2 purinergic (P2) receptors bind extracellular nucleotides and are expressed by major peripheral tissues responsible for glucose homeostasis. CD39/ENTPD1 is the dominant vascular and immune cell ectoenzyme that hydrolyzes extracellular nucleotides to regulate purinergic signaling.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-We have studied Cd39/Entpd1-null mice to determine whether any associated changes in extracellular nucleotide concentrations influence glucose homeostasis.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 711 712 700 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
RESULTS-Cd39/Entpd1-null mice have impaired glucose tolerance and decreased insulin sensitivity with significantly higher plasma insulin levels. Hyperinsulinemic-euglycemic clamp studies indicate altered hepatic glucose metabolism. These effects are mimicked in vivo by injection into wild-type mice of either exogenous ATP or an ecto-ATPase inhibitor, ARL-67156, and by exposure of hepatocytes to extracellular nucleotides in vitro. Increased serum interleukin-1beta, interleukin-6, interferon-gamma, and tumor necrosis factor-alpha levels are observed in Cd39/Entpd1-null mice in keeping with a proinflammatory phenotype. Impaired insulin sensitivity is accompanied by increased activation of hepatic c-Jun NH2-terminal kinase/stress-activated protein kinase in Cd39/Entpd1 mice after injection of ATP in vivo. This results in decreased tyrosine phosphorylation of insulin receptor substrate-2 with impeded insulin signaling.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-CD39/Entpd1 is a modulator of extracellular nucleotide signaling and also influences metabolism. Deletion of Cd39/Entpd1 both directly and indirectly impacts insulin regulation and hepatic glucose metabolism. Extracellular nucleotides serve as "metabolokines," indicating further links between inflammation and associated metabolic derangements.
###end p 6
###begin p 7
Published ahead of print at  on 20 June 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
Purinergic signaling elements comprise a ubiquitous sensing network within the extracellular environment. In this system, extracellular nucleotides, such as ATP, ADP, and UTP, and extracellular nucleosides, such as adenosine, trigger differential cellular responses (1,2). Purinergic signaling pathways require extracellular nucleotide release mechanisms, purinergic receptors for these mediators (type 2 purinergic [P2] receptors), and regulated expression of ectonucleotidases that hydrolyze extracellular nucleotides to generate adenosine (3-5). Extracellular nucleotides are provided by the secretion/release of intracellular substrates, and levels are increased in hypoxia, injury, mechanical stress, and inflammation.
###end p 9
###begin p 10
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 433 435 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 489 490 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 555 557 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 558 560 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 621 623 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 837 839 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 840 842 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
Several reports suggest roles for extracellular nucleotides and nucleosides in glucose homeostasis (e.g., stimulation of insulin secretion from islets [6-8], modulation of glucose uptake [9,10]). P2 receptors are expressed by insulin-sensitive tissues and also by immune cells. Extracellular nucleotides activate inflammatory pathways, inducing expression of proinflammatory cytokines including interleukin-1 (11), interferon-gamma (12), and activating inflammatory kinase such as c-Jun NH2-terminal kinase (c-JNK) through the activation of P2 receptors (13,14). Protein kinase C can be also activated by these pathways (15). These kinases phosphorylate serine residues of insulin receptor substrate (IRS)-1/2, resulting in impaired insulin signaling by precluding tyrosine phosphorylation required to recruit phosphoinositide 3-kinase (16,17).
###end p 10
###begin p 11
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
CD39/ENTPD1 is an ectoenzyme that hydrolyzes extracellular nucleotides and is predominantly expressed in vascular endothelial cells and immune cells. We have previously shown that deletion of Cd39/Entpd1 results in disordered purinergic signaling responses that compromise vascular thromboregulation and augment inflammatory responses (3,5,12). Here, we show that Cd39/Entpd1-null mice demonstrate impaired glucose tolerance secondary, at least in part, to hepatic insulin resistance. This phenomenon is associated with increased levels of hepatocyte c-JNK activation in response to extracellular nucleotides, resulting in aberrant IRS-2 phosphorylation within the livers of the mutant mice. Our studies clearly establish links between extracellular nucleotide-mediated regulation of glucose metabolism and inflammation that are uniquely influenced by the vascular expression of Cd39/Entpd1.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin p 13
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 225 229 <span type="species:ncbi:10090">Mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
Cd39/Entpd1-null mice have been described in detail elsewhere (3) and were backcrossed six times onto the C57BL/6 genetic background. C57BL/6 wild-type mice were obtained from Taconic. Male mice were used in all experiments. Mice were housed under conditions of controlled temperature and illumination (12-h light cycle, lights on at 0700 h). Unless otherwise stated, mice were fed a normal diet ad libitum. All research and animal care protocols were approved by the Beth Israel Deaconess Medical Center Animal Experimentation Ethics Committee.
###end p 13
###begin title 14
Glucose tolerance and insulin tolerance tests.
###end title 14
###begin p 15
###xml 167 168 167 168 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 822 823 822 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
A glucose tolerance test (GTT) was carried out with overnight-fasted (16 h) mice at 9 and 16 weeks old. GTT was performed by intraperitoneal injection of glucose (1 g d-glucose/kg body wt). An insulin tolerance test (ITT) was performed by intraperitoneal injection of human regular insulin (0.75 units insulin/kg body wt; Eli Lilly) at 2 h after removal of food. Blood glucose levels were determined with the OneTouch Ultra blood glucose-monitoring system (LifeScan). To determine effects of exogenous nucleotides on GTT, 7-week-old wild-type mice were fasted overnight. After basal plasma glucose was measured, the experimental mice were injected with ATP, ADP, UTP, or UDP solution (0.5 mmol/kg body wt) intraperitoneally, whereas control animals were administered saline. At 30 min, each animal was subjected to a GTT (n = 5-6 per group). The effects of an ecto-ATPase inhibitor, ARL-67156 (5 mg/kg body wt), on the GTT were examined in a similar manner.
###end p 15
###begin title 16
Hyperinsulinemic-euglycemic clamp study.
###end title 16
###begin p 17
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 403 405 403 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 411 413 411 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 506 507 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 548 549 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 556 557 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 847 849 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 352 357 <span type="species:ncbi:9606">human</span>
Hyperinsulinemic-euglycemic clamp studies were performed on 16- to 17-week-old mice. Four days before experiments, an indwelling catheter was inserted in the right internal jugular vein of experimental animals. After an overnight fast, a 120-min hyperinsulinemic-euglycemic clamp was conducted in awake mice, as previously described (18). Infusions of human insulin (Eli Lilly) at a rate of 15 pmol . kg-1 . min-1 raised plasma insulin levels to approximately900 pmol/l (wild type: 863.0 +/- 151.4 pmol/l [n = 8], knockout: 890.3 +/- 108.4 pmol/l [n = 8]; P = 0.8741), and 40% glucose was infused at variable rates to clamp the plasma glucose levels at approximately6.5 mmol/l using microdialysis pumps. At the end of the clamp studies, each tissue was harvested and frozen in liquid nitrogen. Clamp results were analyzed as described previously (18).
###end p 17
###begin title 18
Measurements of metabolites, serum hormones, and cytokines.
###end title 18
###begin p 19
###xml 47 50 <span type="species:ncbi:10116">rat</span>
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
###xml 433 438 <span type="species:ncbi:10090">mouse</span>
###xml 477 482 <span type="species:ncbi:10090">mouse</span>
Insulin concentrations were determined using a rat insulin enzyme-linked immunosorbent assay (ELISA) kit with mouse insulin standards (Crystal Chem). Serum triglyceride and free fatty acid concentrations were measured using a colorimetric kit (Sigma-Aldrich) and a NEFA-C kit (Wako Chem), respectively. Serum 3-hydroxybutyric acid levels were determined using a colorimetric assay kit (Wako Chem). Plasma leptin was measured using a mouse leptin ELISA kit (Crystal Chem) and a mouse adiponectin radioimmunoassay kit (Linco Research). Urine catecholamine levels were determined by an ELISA kit (Alpco Diagnostics). Serum cytokine levels (interleukin-1beta, interleukin-6, interferon-gamma, and tumor necrosis factor-alpha) were measured by ELISA (eBiosciences).
###end p 19
###begin title 20
Measurements of nuclear factor-kappaB p65.
###end title 20
###begin p 21
Liver nuclear extracts were prepared with the Nuclear Extract Kit (Active Motif), according to the manufacturer's instruction. Nuclear factor-kappaB (NFkappaB) p65 levels in equal amounts of nuclear extracts were determined with TransAM NFkappaBp65 (Active Motif).
###end p 21
###begin title 22
Body composition.
###end title 22
###begin p 23
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
A PIXIMUS Densitometer (LUNAR) was used for the measurement of body composition in anesthetized mice (19).
###end p 23
###begin title 24
Indirect calorimetry and daily activity.
###end title 24
###begin p 25
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 173 174 173 174 <sc xmlns:xlink="http://www.w3.org/1999/xlink">o</sc>
###xml 174 175 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 206 208 206 208 <sc xmlns:xlink="http://www.w3.org/1999/xlink">co</sc>
###xml 208 209 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 230 232 230 232 <sc xmlns:xlink="http://www.w3.org/1999/xlink">co</sc>
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 238 239 238 239 <sc xmlns:xlink="http://www.w3.org/1999/xlink">o</sc>
###xml 239 240 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
In vivo indirect calorimetry was performed in metabolic chambers using an Oxymax system (Columbus Instruments) in mice at 16-17 weeks old. To calculate oxygen consumption (Vo2), carbon dioxide production (Vco2), and RQ (ratio of Vco2 to Vo2), gas concentrations were monitored at the inlet and outlet of the sealed chambers. Global daily activity was monitored by counting the number of times that an individual mouse blocked an infrared beam running along x- and y-axes inside an individual cage.
###end p 25
###begin title 26
Isolation and culture of hepatocytes.
###end title 26
###begin p 27
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Hepatocytes were isolated from 7-week-old mice according to the method of Harman et al. (20). Hepatocytes were further purified by centrifugation with Percoll and plated onto gelatin-coated dishes. Unattached cells were removed at 6 h. The cells were used for experiments at 24-h postisolation.
###end p 27
###begin title 28
Glucose uptake by cultured hepatocytes.
###end title 28
###begin p 29
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 125 126 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 457 458 445 446 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 504 505 492 493 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 507 508 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 819 821 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 826 828 814 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 900 901 888 889 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 903 904 891 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 8 14 <span type="species:ncbi:10090">murine</span>
Primary murine hepatocytes were plated onto six-well plates at 4 x 105 cells/well. The cells were cultured in a 37degreesC CO2 incubator in William's E buffer with 10% FCS. Subsequently, cells were serum starved overnight in William's E buffer with 0.1% BSA. The cells were washed twice with Krebs-Ringer/Pi/Hepes (KRPH) and treated with either 100 nmol/l insulin or KRPH buffer (control) for 30 min at 37degreesC, followed by addition of 10 mmol/l 2-deoxy-d-glucose (2-DG) containing 0.3 mCi/ml 2-deoxy-d-[3H]glucose. After a 10-min incubation, the cells were washed with ice-cold PBS three times, air dried, then lysed with ice-cold 0.2 N NaOH. Radioactivity was determined by scintillation counting, and protein concentrations were determined using the Bio-Rad DC protein assay. 2-DG uptake was expressed as cpm . mg-1 . ml-1 of protein concentration. Similar protocol was used to measure 2-deoxy-d-[3H]glucose uptake in wild-type cells that were either pretreated with 100 mumol/l ATP or KRPH buffer for 30 min before commencing the insulin-stimulated 2-DG uptake assay.
###end p 29
###begin title 30
Measurement of gluconeogenesis in cultured hepatocytes.
###end title 30
###begin p 31
###xml 84 85 84 85 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 496 498 496 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 503 505 503 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
Primary hepatocytes were serum starved overnight in DMEM with 0.4% FCS and 5 mmol/l d-glucose, washed three times with KRPH buffer, and incubated with KRPH buffer containing 20 mmol/l lactate and 2 mmol/l pyruvate (basal) or KRPH buffer containing either 10 nmol/l insulin or 100 nmol/l insulin with 20 mmol/l lactate and 2 mmol/l pyruvate. Glucose content in each aliquot was measured using an Amplex Red Glucose Assay (Invitrogen). Glucose production was expressed as measured fluorescence . mg-1 . ml-1 of protein concentration. Similar experimental protocol was used to measure glucose production in wild-type cells that were either pretreated with 100 mumol/l ATP or KRPH buffer for 30 min before commencing the insulin-stimulated gluconeogenesis assay.
###end p 31
###begin title 32
Western blotting.
###end title 32
###begin p 33
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 804 805 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Tissue or cell lysates were prepared in the lysis buffer as described previously (18). Clarified supernatant was separated on SDS-PAGE under reducing condition and then transferred to polyvinylidene fluoride membrane for Western blot analysis. For IRS-1 and -2 studies, 500 mug of cleared lysate was incubated with anti-IRS-1 or anti-IRS-2 antibodies (Upstate) then captured with protein-A/G Sepharose beads (Sigma-Aldrich). After washing the beads, IRS-1 or -2 was eluted in SDS-loading buffer and subjected to Western blot analysis with anti-phosphotyrosine antibody or anti-IRS-1 or anti-IRS-2 antibodies. Images were taken on a Kodak chemiluminescent image station 2000MM and quantified with an accompanying software program (Kodak). Detection of either phospho-JNK or JNK was carried out using anti-p-JNK antibody or anti-JNK antibody (Cell Signaling Technolgies). Phospho-Ser731-IRS-2 was detected using specific antibodies purchased from Abcam.
###end p 33
###begin title 34
Administration of ATP into portal vein.
###end title 34
###begin p 35
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
Twelve-week-old male mice were anesthetized with nembutal then 10 mmol/l ATP, and PBS was administered via a portal vein at 1.4 mul/g and at 2.5 s/g body wt using a microinfusion pump. At 30 min of infusion, mice were killed by exsanguination, and immediately the perfused liver was snap frozen in liquid nitrogen.
###end p 35
###begin title 36
Immunohistochemistry.
###end title 36
###begin p 37
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
Animals were anesthetized with avertin and killed by exsanguination. Pancreatic, hepatic, and skeletal muscle tissues were immediately embedded in OCT compound in an isopentene-liquid nitrogen freezing bath. Brown adipose tissue (BAT) was fixed in zinc fixative solution (BD Biosciences) for 1.5 days. The tissue sections were used for immunohistochemical staining with antibodies against Cd39/Entpd1 (3), Cd31 (BD Biosciences), insulin, and glucagon (Dako).
###end p 37
###begin title 38
Real-time PCR for gluconeogenetic enzymes.
###end title 38
###begin p 39
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
Liver total RNA was purified with a Qiagen RNAeasy mini-kit and used to synthesis cDNA using an Invitrogen first-strand cDNA synthesis kit. Real-time PCR was performed with a iTaq SYBR Green Supermix with ROX (Bio-Rad) on a Stratagene MX3000P quantitative PCR system. The primers used were TGGTAGCCCTGTCTTTCTTTG and TTCCAGCATTCACACTTTCCT for glucose-6-phosphatase and ACACACACACATGCTCACAC and ATCACCGCATAGTCTCTGAA for phosphoenolpyruvate carboxylase (21). Actin values were used for normalization.
###end p 39
###begin title 40
RESULTS
###end title 40
###begin title 41
Cd39/Entpd1 deletion results in abnormalities in GTTs and ITTs.
###end title 41
###begin p 42
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 94 100 94 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 227 234 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 318 321 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 406 409 406 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 422 423 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 416 423 416 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 513 514 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 507 514 507 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 528 531 528 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 735 738 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
Cd39/Entpd1 knockout (Cd39/Entpd1-/-) mice were subjected to GTTs and ITTs at 9 weeks of age (Fig. 1). Blood glucose levels were significantly higher in Cd39/Entpd1-/- mice throughout the GTT when compared with wild-type mice (Fig. 1A). Plasma insulin levels during the GTT were also consistently higher in Cd39/Entpd1-/- mice when compared with wild-type mice, suggesting insulin resistance in Cd39/Entpd1-/- mice (Fig. 1B). Cd39/Entpd1-/- mice also exhibited impaired responses to insulin during the ITT (Fig. 1C). Cd39/Entpd1-/- mice at 16 weeks likewise exhibited glucose intolerance and insulin resistance as determined by a GTT and ITT. There were no differences in fasting- and fed-state blood glucose levels between Cd39/Entpd1-/- and wild-type mice.
###end p 42
###begin p 43
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 195 202 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 433 434 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 427 440 427 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic> and E</xref>
###xml 605 606 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 599 606 599 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>F</italic></xref>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
We then examined effects of exogenous nucleotide administration upon a GTT in wild-type mice. Increases in blood glucose levels were observed at 30 min after administration of ATP versus saline (Fig. 1D). These plasma glucose increments were sustained in the group treated with ATP during the GTT. The preadministration of other nucleotides, UTP, ADP, and UDP, did not substantially affect glucose tolerance in wild-type mice (Fig. 1D and E). Preadministration of ARL-67156, a competitive ecto-ATPase inhibitor, resulted in increases in glucose levels basally and following a GTT in wild-type mice (Fig. 1F).
###end p 43
###begin title 44
Metabolic parameters.
###end title 44
###begin p 45
###xml 166 173 166 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 187 190 187 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 285 288 285 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 339 342 339 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 429 432 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 574 577 574 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 735 738 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
Insulin resistance is often accompanied by obesity and disordered lipid metabolism. We therefore assessed other parameters relevant to these disorders of metabolism (Table 1). Cd39/Entpd1-/- mice are clearly not obese. Plasma insulin levels were significantly higher in fed Cd39/Entpd1-/- mice at all ages tested and in fasting Cd39/Entpd1-/- mice at 16 weeks of age. Plasma free fatty acid and triglyceride levels in Cd39/Entpd1-/- mice were not generally different from wild-type mice but became statistically higher at 35 weeks of age. Plasma leptin levels of Cd39/Entpd1-/- mice were significantly higher than in wild-type mice, but adiponectin levels were comparable. Plasma 3-hydroxybutyrate levels were comparable in Cd39/Entpd1-/- mice and wild-type mice.
###end p 45
###begin p 46
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 269 270 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 305 308 301 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 376 377 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
We also examined sympathetic reactivity in Cd39/Entpd1e-/- mice. Total adrenaline and noradrenaline levels in urine were not statistically different between these two groups (adrenaline: Cd39/Entpd1-/- mice 1.49 +/- 0.50 pg/day vs. wild-type mice 1.64 +/- 0.48 pg/day, P = 0.83; noradrenoline: Cd39/Entpd1-/- mice 2.76 +/- 0.90 pg/day vs. wild-type mice 3.06 +/- 0.73 pg/day, P = 0.79).
###end p 46
###begin title 47
Energy expenditure and activity.
###end title 47
###begin p 48
###xml 69 75 69 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 95 102 95 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 131 132 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 125 132 125 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 159 166 159 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 309 312 309 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 364 371 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
We examined the impact of Cd39/Entpd1 deletion on energy metabolism (Fig. 2). Heat generation (Fig. 2A), oxygen consumption (Fig. 2B), and respiratory ratio ((Fig. 2C) were significantly lower in Cd39/Entpd1-/- mice, both during dark and light periods. However, food intake and daily activities of Cd39/Entpd1-/- mice were comparable with those of wild-type mice (Fig. 2D).
###end p 48
###begin title 49
Hyperinsulinemic-euglycemic clamp studies.
###end title 49
###begin p 50
###xml 196 199 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 220 227 220 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 327 330 327 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 337 344 337 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 391 392 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 419 422 419 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 429 436 429 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 604 607 604 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 625 628 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 685 686 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 703 704 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 697 704 693 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 800 803 796 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 882 883 878 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 883 884 879 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
To analyze systemic glucose uptake and usage, we performed hyperinsulinemic-euglycemic clamp studies. Glucose uptake in the extrahepatic tissues was not statistically different between Cd39/Entpd1-/- and wild-type mice (Fig. 3A). Glucose infusion rates during the glucose clamp were, however, significantly lower in Cd39/Entpd1-/- mice (Fig. 3B). Coincidently, glucose disappearance rates (Rd) were lower in Cd39/Entpd1-/- mice (Fig. 3C). Basal hepatic glucose production was normal, but the extent of insulin-dependent suppression of hepatic glucose production was significantly decreased in Cd39/Entpd1-/- mice (Cd39/Entpd1-/- mice: 26.6 +/- 14.4% vs. wild-type mice: 69.5 +/- 9.6%; P = 0.021) (Fig. 3D). These results suggest that systemic insulin resistance and glucose intolerance of Cd39/Entpd1-/- mice were associated with impaired hepatic responses to insulin and decreased Rd.
###end p 50
###begin p 51
###xml 127 130 127 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 216 219 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 276 277 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 321 324 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 381 382 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
Phosphoenolpyruvate carboxylase and glucose-6-phosphatase expression by RT-PCR were significantly higher in fasting Cd39/Entpd1-/- mice liver than in wild-type mice liver (phosphoenolpyruvate carboxylase: Cd39/Entpd1-/- mice 128.8 +/- 10.2% vs. wild-type mice 100.0 +/- 0.6%, P = 0.027; glucose-6-phosphatase: Cd39/Entpd1-/- mice 240.6 +/- 26.1% vs. wild-type mice 100.0 +/- 7.3%, P = 0.001).
###end p 51
###begin title 52
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Localization of Cd39/Entpd1 in mouse liver, pancreas, BAT, and skeletal muscle.
###end title 52
###begin p 53
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
High levels of Cd39/Entpd1 staining were observed in the endothelium with the same expression in vascular smooth muscle cells of muscularized blood vessels within liver and skeletal muscle. Hepatic sinusoidal endothelial cells do not express Cd39/Entpd1 under basal conditions; however, Cd39/Entpd1 is expressed by certain hepatic sinusoidal cells (e.g., Kupffer cells and natural killer T-cells) (22,23).
###end p 53
###begin p 54
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 69 82 69 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic> and <italic>B</italic></xref>
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 248 255 248 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 383 384 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 389 390 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 377 390 377 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>D</italic> and <italic>I</italic></xref>
###xml 646 649 635 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 708 709 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 714 715 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 702 715 691 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>K</italic> and <italic>O</italic></xref>
###xml 729 732 718 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 776 777 765 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 782 783 771 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 770 783 759 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>L</italic> and <italic>P</italic></xref>
Hepatocytes and skeletal muscle cells were negative for Cd39/Entpd1 (Fig. 4A and B). In brown adipose tissue, Cd39/Entpd1 expression was likewise restricted to the vascular endothelium of veins and arterioles but not noted in the microvasculature (Fig. 4C). In pancreas, the expression was also detected only in the vascular endothelial cells and vascular smooth muscle cells (Fig. 4D and I). In islets of Langerhans of the pancreas, the beta-, alpha-, and delta-cells were all negative for Cd39/Entpd1. However, the microvasculature endothelial cells did stain for Cd39/Entpd1 in the pancreatic tissues and islets. Both wild-type and Cd39/Entpd1-/- islets stained for glucagon in a comparable manner (Fig. 4K and O); Cd39/Entpd1-/- islets reacted strongly for insulin (Fig. 4L and P).
###end p 54
###begin title 55
Effect of extracellular ATP on glucose metabolism in hepatocytes.
###end title 55
###begin p 56
###xml 93 96 93 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 213 216 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 290 293 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 316 323 316 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
We next analyzed glucose metabolism in cultured primary hepatocytes isolated from Cd39/Entpd1-/- mice, as hyperinsulinemic-euglycemic clamp studies had suggested impaired hepatic glucose homeostasis in Cd39/Entpd1-/- mice. Overall glucose uptakes were significantly decreased in Cd39/Entpd1-/- hepatocytes in vitro (Fig. 5A).
###end p 56
###begin p 57
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 96 103 96 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 392 395 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 600 601 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 594 601 594 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 749 750 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 743 750 743 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>D</italic></xref>
The glucose uptake by wild-type hepatocytes was significantly decreased in the presence of ATP (Fig. 5B). Major contributions of liver to systemic glucose homeostasis involve regulation of glucose production that is suppressed by insulin. Glucose production was much higher in Cd39/Entpd1-/- hepatocytes than the wild-type hepatocytes. The increased level of glucose production by Cd39/Entpd1-/- hepatocytes was not significantly suppressed by insulin. In contrast, wild-type hepatocytes had the expected statistically significant suppression by insulin with respect to the glucose production (Fig. 5C). Exogenous extracellular ATP also induced higher levels of glucose production in wild-type hepatocytes; this was not suppressed by insulin (Fig. 5D).
###end p 57
###begin title 58
Susceptibility of c-JNK phosphorylation by exogenous ATP treatment.
###end title 58
###begin p 59
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 511 514 511 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 616 617 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 610 617 610 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 326 329 <span type="species:ncbi:10116">rat</span>
###xml 395 400 <span type="species:ncbi:10090">mouse</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
c-JNK is a member of mitogen-activated protein kinase family that is activated by various proinflammatory cytokines. The activated c-JNK phosphorylates serine residues of IRS-1/2 and consequently prevents tyrosine phosphorylation of IRS-1/2 by insulin receptor (16). As extracellular ATP treatment induces c-JNK activation in rat hepatocytes (14), we examined phosphorylation levels of c-JNK in mouse liver after portal venous administration of ATP in vivo. We noted that phosphorylation of c-JNK in Cd39/Entpd1-/- mice liver at 30 min after ATP administration was significantly higher than in wild-type mice (Fig. 6A).
###end p 59
###begin title 60
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Decreased tyrosine phosphorylation of hepatic IRS-2 in Cd39/Entpd1-/- mice.
###end title 60
###begin p 61
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 365 368 365 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 544 547 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 597 603 597 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7</xref>
###xml 687 690 687 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 846 849 846 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 904 905 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 898 905 898 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>D</italic></xref>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 691 697 <span type="species:ncbi:10090">murine</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
Tyrosine phosphorylation of IRS could be hampered by phosphorylation of adjacent serine residues of IRS mediated by inflammatory kinase such as c-JNK or protein kinase C (16,17). Such kinases are activated through the activation of purinergic receptors by extracellular ATP (14,15). We therefore examined phosphorylation of IRS-1 and -2 in wild-type and Cd39/Entpd1-/- mice liver to dissect out differential responses to insulin in vivo. There were no differences in levels of tyrosine phosphorylation of IRS-1 between wild-type and Cd39/Entpd1-/- mice liver samples after insulin administration (Fig. 7). However, tyrosine phosphorylation of IRS-2 was markedly suppressed in Cd39/Entpd1-/- murine liver relative to wild-type samples postinjection of insulin. Relative levels of hepatic Ser-731 phosphorylation of IRS-2 were higher in Cd39/Entpd1-/- mice when compared with wild-type mice tissues (Fig. 7D).
###end p 61
###begin title 62
Serum proinflammatory cytokine levels.
###end title 62
###begin p 63
###xml 328 331 328 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 468 471 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 501 508 490 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 565 568 550 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 619 622 604 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 695 696 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
Increased levels of proinflammatory cytokines are known to induce insulin resistance by activating kinases such as c-JNK. Extracellular nucleotides also clearly activate inflammatory pathways. Therefore, we have measured the serum levels of proinflammatory cytokines as surrogates for basal inflammatory responses in Cd39/Entpd1-/- mice. Interleukin-6, interleukin-1beta, interferon-gamma, and tumor necrosis factor-alpha levels are significantly higher in Cd39/Entpd1-/- mice than in wild-type mice (Table 1). NFkappaBp65 levels were also higher in the Cd39/Entpd1-/- mice liver treated with exogenous ATP (Cd39/Entpd1-/- mice 178.5 +/- 24.1 vs. wild-type mice 100.0 +/- 9.5 [arbitrary units]; P = 0.0019).
###end p 63
###begin title 64
DISCUSSION
###end title 64
###begin p 65
###xml 186 189 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 336 339 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
We have shown that deletion of Cd39/Entpd1 results in abnormalities of glucose homeostasis and causes insulin resistance. We show that the plasma insulin levels are higher in Cd39/Entpd1-/- mice than in wild-type mice during a GTT, and islets stain strongly for insulin in Cd39/Entpd1-/- mice tissues. Glucose intolerance in Cd39/Entpd1-/- mice does not appear to be related to an intrinsic abnormality in insulin secretion from beta-cells. Significant effects of ATP administration on the GTT in contrast to other nucleotides suggest involvement of P2X receptors that are uniquely activated by ATP in the expression of glucose intolerance.
###end p 65
###begin p 66
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 334 337 334 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 532 535 532 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 667 670 667 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 967 970 967 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
Cd39/Entpd1-/- mice are not obese, but leptin levels are increased. Leptin is an important anorexigenic hormone secreted from adipocytes (24-26). Insulin may induce secretion of leptin (27). Therefore, it is possible that the hyperinsulinemia of Cd39/Entpd1-/- mice might be a cause for hyperleptinemia. The food intake of Cd39/Entpd1-/- mice was comparable with those of wild-type mice despite the increased levels of plasma leptin. Leptin is also known to increase energy expenditure. However, calorimetric analysis of Cd39/Entpd1-/- mice revealed decreased heat generation and energy consumption both during dark and light cycles. Respiratory ratios of Cd39/Entpd1-/- mice were slightly lower than wild-type mice. Potentially, other tissue-specific mechanisms might exist for the regulation of energy consumption by extracellular nucleotides. Our current data, however, suggest the possibility of both leptin resistance as well as insulin resistance in Cd39/Entpd1-/- mice.
###end p 66
###begin p 67
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
Hyperinsulinemic-euglycemic clamp studies identified the liver as a major target organ for the effects of Cd39/Entpd1 on glucose homeostasis and insulin resistance. Immunohistochemical studies showing Cd39/Entpd1 to be expressed dominantly within the vasculature suggest that observed insulin resistance are secondary to modulation of extracellular and plasma nucleotides levels brought by loss of vascular ecto-nucleotidase activity. This is different mechanistically from the type of insulin resistance induced by a K121Q variant of PC-1 (ectonucleotide pyrophosphatase/phosphodiesterase). The latter requires direct/physical interactions between insulin receptor and PC-1 (28,29). Furthermore, PC-1 is expressed in skeletal muscle cells and hepatocytes unlike the unique vascular expression of Cd39/Entpd1.
###end p 67
###begin p 68
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 329 332 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 525 528 525 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 775 778 775 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1041 1042 1041 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1042 1043 1042 1043 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 1073 1076 1073 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 1077 1081 <span type="species:ncbi:10090">mice</span>
We next examined aspects of glucose metabolism in primary hepatocyte cultures of Cd39/Entpd1-/- and wild-type mice. In general, glucose transport by hepatocytes is insulin-independent. However, expression of glucokinase is induced by insulin. We noted that the overall uptake of glucose was significantly decreased in Cd39/Entpd1-/- mice hepatocytes. Glucose uptake by wild-type primary culture hepatocyte was also significantly decreased by treatment with extracellular ATP, albeit not to the same extent as with Cd39/Entpd1-/- hepatocytes. ATP is known to induce hepatic gluconeogenesis (30) and impact upon glucose release via P2X4 receptor-mediated increases in glycogenolysis (31). Our and these published data suggest that the cellular phenotype seen in the Cd39/Entpd1-/- mice may be directly dependent upon exposure to extracellular nucleotides. We suggest that these are differential and persistent purinergic responses in these target tissues that are impacted upon by loss of Cd39/Entpd1 in vasculature. We infer that the reduced Rd values observed in Cd39/Entp1-/- mice during the hyperinsulinemic-euglycemic studies are secondary due, in substantial part, to the decreased glucose uptake in hepatocytes.
###end p 68
###begin p 69
###xml 368 371 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
Other contributions of insulin to hepatic glucose homeostasis include the suppression of glucose production. Liver-specific insulin receptor knockout mice exhibit hepatic insulin resistance (i.e., impaired insulin-mediated suppression of hepatic glucose production that is accompanied by elevated plasma insulin levels). These features are also observed in Cd39/Entpd1-/- mice, suggesting indirect effects on insulin receptor activity (32).
###end p 69
###begin p 70
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 184 187 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 990 993 990 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 887 891 <span type="species:ncbi:10090">mice</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
Cd39/Entpd1-/- mice hepatocytes also show significantly higher basal glucose production than that seen in wild-type mice hepatocytes. Furthermore, the glucose production of Cd39/Entpd1-/- mice hepatocytes is not suppressed by the treatment of insulin, unlike in the instance of wild-type mice hepatocytes, in which this is suppressed by insulin. Interestingly, ATP treatment of wild-type hepatocytes also induces heightened hepatic glucose production, even in the presence of insulin. These results confirm that extracellular ATP regulates glucose homeostasis in hepatocytes. Furthermore, Cd39/Entpd1 expressed on adjacent cells, such as endothelial cells, is likely to regulate insulin signals in the hepatocyte by modulating extracellular nucleotide levels in the immediate microenvironment in vivo. It is worthy of mention that vascular endothelial-specific insulin receptor knockout mice do not exhibit insulin resistance (33). We propose that insulin resistance observed in Cd39/Entpd1-/- mice is not directly caused by modulation of vasculature functions but involves other factors (e.g., paracrine fluxes of extracellular nucleotides that impact target tissues such as the hepatocyte).
###end p 70
###begin p 71
###xml 160 162 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 535 537 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 538 540 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
Activation of cellular signaling cascades by proinflammatory cytokines such as tumor necrosis factor-alpha and interleukin-1, free fatty acids, or nucleotides (14) can also induce cellular activation via inflammatory kinases. Activation of inflammatory kinases, such as c-JNK, also cause aberrant serine phosphorylation of IRS. This specific form of serine phosphorylation prevents consequent tyrosine phosphorylation by insulin receptors and association of phosphoinositide 3-kinases, leading to impaired insulin signal transduction (34,35).
###end p 71
###begin p 72
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 366 369 366 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 439 442 439 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
To analyze the molecular mechanisms for insulin resistance of Cd39/Entpd1-/- mice, we analyzed tyrosine phosphorylation of IRS-1 and -2. Insulin-stimulated tyrosine phosphorylation of IRS-2 was significantly decreased in Cd39/Entpd1-/- mice liver. In addition, phosphorylation of c-JNK induced by administration of ATP was also significantly increased in Cd39/Entpd1-/- mice liver. These data suggest that insulin resistance of Cd39/Entpd1-/- mice is associated with increased activation of hepatic c-JNK/SAP by extracellular ATP. This likely results in aberrant serine phosphorylation and consequently decreased tyrosine phosphorylation of IRS-2. Similar patterns of aberrant IRS-2 phosphorylation have been noted in other insulin resistance states (36).
###end p 72
###begin p 73
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 233 236 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 361 363 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
Furthermore, several features observed in Cd39/Entpd1-/- mice are also seen in IRS-2-/- mice: both show elevated plasma insulin levels and have normal fasting blood glucose levels with impaired glucose homeostasis in the liver. IRS-2-/- mice, however, show increases in blood glucose levels with advancing age due to lack of compensatory beta-cell hyperplasia (37).
###end p 73
###begin p 74
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r42">42</xref>
###xml 522 525 511 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 728 731 717 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
Other cellular candidates for mediating insulin resistance of Cd39/Entpd1-/- mice include immune cells such as macrophages in adipose tissues and the Kupffer cells of the liver, as alluded to above (35). Activation of purinergic signaling pathways is already known to induce secretion of cytokines from both immune and endothelial cells (38-42). We show that serum proinflammatory cytokine levels (interleukin-1beta, interleukin-6, interferon-gamma, and tumor necrosis factor-alpha) are significantly higher in Cd39/Entpd1-/- mice than in wild-type mice. Accordingly, hypersecretion of select cytokines by monocytes and other cells also might contribute, at least in part, to the development of insulin resistance in Cd39/Entpd1-/- mice.
###end p 74
###begin p 75
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Our data suggest that insulin resistance in Cd39/NTPDase1-/- mice is associated with disordered extracellular nucleotide signaling that directly impacts important metabolic pathways in hepatocytes via aberrant IRS-2 phosphorylation. However, we do not exclude the possibility that deletion of Cd39 might also contribute to insulin resistance in a somewhat more indirect manner via the induction of inflammatory cytokines. The relative contributions of these two nonexclusive mechanisms remain to be determined.
###end p 75
###begin p 76
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r42">42</xref>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
We have already reported on other vascular and immune abnormalities in Cd39/Entpd1-/- mice. This described phenotype includes disordered thromboregulation, aberrant inflammatory responses, impaired angiogenesis and regeneration of the liver, impaired function of regulatory T-cells, and predisposition to diabetic renal diseases with increased proteinuria and hypertension (3,5,12,15,42). To these manifestations of Cd39/Entpd1 deletion, we now add metabolic consequences.
###end p 76
###begin p 77
In conclusion, Cd39/Entpd1 expressed by the vasculature and by immune cells serves as an important modulator of hepatic carbohydrate metabolism. The pathogenetic mechanism involves failure to control extracellular nucleotide fluxes that both directly and indirectly impact insulin responsiveness.
###end p 77
###begin p 78
This work was supported by American Heart Association Grant AHA 0530362N (to K.E.); by National Institutes of Health Grants NIH HL063972 (to S.C.R.), HL076540 (to S.C.R.), and NIDDK 43051 (to B.B.K); and an American Diabetes Association Mentor-Based Fellowship (to B.B.K.).
###end p 78
###begin title 79
REFERENCES
###end title 79
###begin p 80
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 159 162 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 206 207 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 214 215 196 197 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 214 215 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sc>d</sc></italic>
###xml 216 217 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 278 279 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 288 289 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 402 403 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 516 517 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 626 627 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 637 638 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
Cd39/Entpd1-/- mice exhibit impaired glucose tolerance and insulin resistance. A: GTT. B: Plasma insulin levels during GTT. C: ITT. black triangle, Cd39/Entpd1-/- mice; square, wild-type mice (9 weeks old, n = 6). d-F: Effects of different nucleotides on GTT in wild-type mice (n = 5-6). D: open diamond, ATP-treated mice; black triangle, UTP-treated mice; blacksquare, square, filled, saline control. E: open diamond, ADP-treated mice; black triangle, UDP-treated mice; blacksquare, square, filled, saline control. F: triangle up, ARL-67156-treated mice; blacksquare, square, filled, saline control. Data are means +/- SE. **P < 0.05; *P < 0.1.
###end p 80
###begin p 81
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 253 254 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 293 294 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 348 351 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 442 443 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
Calorimetric and functional analyses of Cd39/Entpd1-/- mice. Cd39/Entpd1-/- mice showed decreased energy expenditure. Food uptake did not differ between Cd39/Entpd1-/- and wild-type mice. A: Oxygen consumption. B: Heat generation. C: Respiratory ratio. D: Accumulated food intake over 3 days (n = 6 for wild-type -WT] mice and n = 7 for Cd39/Entpd1-/- mice). Results were analyzed using data from 3 consecutive days. Data are means +/- SE. **P < 0.05.
###end p 81
###begin p 82
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 209 210 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 216 217 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 259 262 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 298 299 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 400 403 343 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 469 470 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 493 494 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 514 517 439 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 569 570 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
Cd39/Entpd1-/- mice manifest impaired hepatic glucose homeostasis during hyperinsulinemic-euglycemic clamp. A: Tissue glucose uptake estimated by 2-DG. B: Glucose infusion rate. C: Glucose disappearance rate (Rd). A-C: blacksquare, square, filled, Cd39/Entpd1-/- mice; square, wild-type (WT) mice. D: Hepatic glucose production and its suppression by insulin. blacksquare, square, filled, Cd39/Entpd1-/- mice; square, wild-type (WT) mice; black triangle, with insulin (n = 6 for wild-type and n = 7 for Cd39/Entpd1-/- mice); solid bars, basal. Data are means +/- SE. **P < 0.05.
###end p 82
###begin p 83
###xml 197 215 197 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower right panels</italic>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 319 320 319 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 329 330 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 350 351 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 417 418 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 423 424 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 464 465 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 467 486 467 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inserted microimage</italic>
###xml 513 516 513 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 535 538 535 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 592 593 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 627 628 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 676 677 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 682 683 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 720 721 720 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 738 739 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 773 774 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 791 792 791 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
Immunohistochemical analysis. Various insulin-sensitive tissues together with pancreatic islets were analyzed for Cd39 expression and are compared with the vascular endothelial marker Cd31. In the lower right panels, islet content of glucagon and insulin are also displayed. A-D, I, and M: Expression of Cd39/Entpd1. E-H, J, and N: Stained for Cd31. A and E: From wild-type liver. B and F: Wild-type skeletal muscle. C and G: Wild-type brown adipose tissue (BAT). C: Inserted microimage, at large magnification. (+/+), wild-type BAT. (-/-), Cd39/Entpd1-null BAT serves as a negative control. D and H: Wild-type pancreas. I and J are islet tissues from wild-type mice, whereas M and N are from the Cd39/Entpd1-null mice. K (wild type) and O (null) are stained for glucagon. L (wild type) and P (null) show the staining patterns for insulin (see text for details). (Please see  for a high-quality digital representation of this figure.)
###end p 83
###begin p 84
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 141 142 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 262 265 262 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 339 340 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 464 465 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 507 510 481 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 541 542 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 547 548 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 612 613 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 623 624 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 645 646 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 667 668 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
Effect of extracellular ATP on glucose metabolism in hepatocytes. A: 2-DG uptake by Cd39/Entpd1-/- mice and wild-type (WT) mice hepatocytes. B: Effect of extracellular ATP on 2-DG uptake by wild-type mice hepatocytes. C: Hepatic glucose production of Cd39/Entpd1-/- mice and wild-type (WT) mice hepatocytes and its suppression by insulin. D: Effect of extracellular ATP on glucose production in wild-type hepatocytes. Experiment was performed in triplicate. A and C: blacksquare, square, filled, Cd39/Entpd1-/- mice; square, wild-type mice. B and D: square, without ATP; blacksquare, square, filled, with ATP. **P < 0.05; *P > 0.05 by ANOVA but P < 0.05 by Student's t test.
###end p 84
###begin p 85
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 381 384 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 420 421 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 461 462 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 508 509 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 546 547 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 613 614 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 692 695 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 704 705 625 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 715 716 636 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 737 738 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 759 760 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 25 31 <span type="species:ncbi:10090">murine</span>
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 582 588 <span type="species:ncbi:10090">murine</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
c-JNK phosphorylation in murine liver. Mice were administered ATP via portal vein and the liver was harvested at 30 min after injection. The lysates were analyzed by Western blotting with anti-phospho-JNK antibodies or anti-JNK antibodies. A: Quantification of p-JNK to total JNK ratio by Western blot analysis. square, wild-type (WT) mice; blacksquare, square, filled, Cd39/Entpd1-/-; black triangle, ATP-treated mice (n = 3); solid bars, saline control mice. B: Representative staining of Western blot for p-JNK and JNK. P, a positive control. C: Quantification of NFKappaBp65 in murine liver nuclear extracts (n = 8-9). blacksquare, square, filled, wild-type (WT) mice; square, Cd39/Entpd1-/- mice. **P < 0.05; *P > 0.05 by ANOVA but P < 0.05 by Student's t test.
###end p 85
###begin p 86
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 395 396 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 538 541 507 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 614 615 570 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 624 625 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 634 635 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 681 682 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 709 710 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 730 731 686 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 786 787 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 796 797 752 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 806 807 762 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 853 854 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
Impaired tyrosine phosphorylation of IRS-2 in Cd39/Entpd1-/- liver. Age-matched 12- to 15-week-old male mice were starved for 16 h (1700-1000h) then received human regular insulin at 5 units/kg body wt i.v., and the tissues were collected at 5 min after injection. Lysates were immunoprecipitated with anti-IRS antibodies and protein A/G Sepharose and then probed with anti-tyrosine antibodies. A: Quantification of p-IRS-1/2 to total IRS-1/2 by Western blot analysis. square, wild-type (WT) mice; blacksquare, square, filled, Cd39/Entpd1-/- mice; black triangle, insulin-treated mice; solid bars, saline treated (n = 3). **P < 0.05. B: Representative staining of Western blot for p-IRS-1/2 or total IRS-1/2. C: Quantification of p-Ser731-IRS-2 to total IRS-2 by Western blot analysis (n = 3). **P < 0.05. D: Representative staining of Western blot for p-Ser731-IRS-2 or total IRS-2.
###end p 86
###begin p 87
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
Comparison of blood analysis data of Cd39/Entpd1-/-
###end p 87
###begin p 88
Data are mean +/- SE from 6-10 animals of each group.
###end p 88

